Hilig, Shairah .
HRN: 23-91-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2023
CEFUROXIME 750MG (VIAL)
11/28/2023
11/29/2023
IV
1.5gm 3 Doses
Q8
SP CS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes